You are here

Bayer

Positive data on Kerendia in chronic kidney disease and type 2 diabetes

Pharma Letter

Mon, 08/29/22 - 10:38 am

chronic kidney disease

Bayer gets FDA nod to extend use of popular contraceptive IUD Mirena

Endpoints

Sun, 08/28/22 - 10:08 pm

Revealed: which pharma companies leading the way in artificial intelligence

Clinical Trials Arena

Fri, 08/26/22 - 10:37 am

artificial intelligence

Johnson & Johnson

Bristol Myers Squibb

Merck, seeking XI factor in race with Bayer, gets FDA fast-track tag for anticoagulant

Fierce Biotech

Tue, 08/23/22 - 10:32 am

end-stage renal disease

ESC 2022 preview – who’s got the XI factor?

EP Vantage

Tue, 08/23/22 - 10:23 am

Bristol Myers Squibb

Bayer gets FDA nod to extend use of popular contraceptive IUD Mirena

Endpoints

Thu, 08/18/22 - 11:16 pm

After Roe ruling, Bayer enlists lobbyists to fight for contraceptive access

Fierce Pharma

Thu, 08/11/22 - 11:26 pm

Kodiak matches Regeneron’s Eylea in macular edema phase 3, lighting Beacon of hope after flop

Fierce Biotech

Tue, 08/9/22 - 06:34 am

Kodiak Sciences

clinical trials

Merck plans to count coughs and months until gefapixant is back in FDA hands

Fierce Biotech

Fri, 08/5/22 - 10:54 am

Bayer CEO Werner Baumann says company is 'putting major litigation behind us' while highlighting Q2 growth

Endpoints

Thu, 08/4/22 - 06:15 pm

July Brings Layoffs, Job Creation for the Life Sciences

BioSpace

Wed, 08/3/22 - 09:32 pm

Eikon Therapeutics

Heron Therapeutics

Adverum Biotechnologies

X4 Pharmaceuticals

Assembly Biosciences

Bayer-Ionis' anti-thrombotic med doesn't increase bleeding in phase 2, setting stage for a new type of anticoagulant

Fierce Biotech

Thu, 07/28/22 - 05:54 pm

Ionis Pharmaceuticals

clinical trials

In $500M deal, Bayer offloads testosterone deficiency drug Nebido to Grünenthal

Fierce Pharma

Thu, 07/14/22 - 07:58 pm

Follow-Up Data on Bayer’s Larotrectinib Hints at Potentially Curative Impact

BioSpace

Thu, 07/7/22 - 10:29 am

Bayer AG opens Kendall Square research center focused on cancer

Boston Globe, MA

Fri, 07/1/22 - 09:46 am

Move over Medtech, Pharma Is Embracing AI, Too!

Medical Devices and Diagnostics Industry

Wed, 06/29/22 - 05:29 pm

machine learning

artificial intelligence

ADA: Bayer builds its case for potential kidney disease blockbuster Kerendia

Fierce Pharma

Tue, 06/7/22 - 10:13 am

chronic kidney disease

Bayer pulls plug on $670M CAR-T cell therapy pact with Atara in wake of patient death

Fierce Biotech

Fri, 05/20/22 - 10:22 am

Atara Biotherapeutics

clinical trials

Bayer's farming business drives Q1 earnings beat

Yahoo/Reuters

Tue, 05/10/22 - 10:53 am

Aiming to treat Parkinson’s by replacing neurons, Aspen Neuroscience nabs $147M

MedCity News

Mon, 05/9/22 - 11:22 pm

Parkinson's Disease

Pages